新亚强(603155) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥275,216,940.24, representing a 25.68% increase compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2022 was ¥73,608,275.59, showing a decrease of 10.88% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥69,101,543.48, down by 9.00% compared to the previous year[3]. - The basic earnings per share for Q3 2022 was ¥0.33, a decrease of 10.81% compared to the same period last year[3]. - The net profit for Q3 2022 was CNY 264,742,592.84, an increase of 15.4% compared to CNY 229,355,399.95 in Q3 2021[19]. - The total comprehensive income for Q3 2022 was CNY 264,742,592.84, an increase from CNY 229,355,399.95 in Q3 2021, representing a growth of 15.4%[20]. - Net profit for the first three quarters of 2022 was ¥264,289,219.25, up 15.2% from ¥229,355,399.95 in the previous year[30]. Revenue and Costs - Total operating revenue for the first three quarters of 2022 reached RMB 940,585,075.66, a significant increase from RMB 633,377,672.84 in the same period of 2021, representing a growth of approximately 48.4%[18]. - Total operating costs for the first three quarters of 2022 were RMB 666,842,810.04, compared to RMB 402,619,339.76 in the first three quarters of 2021, indicating an increase of about 65.7%[18]. - The total revenue for the first three quarters of 2022 reached ¥940,578,279.27, a significant increase of 48.4% compared to ¥633,377,672.84 in the same period of 2021[29]. Cash Flow - The cash flow from operating activities for the year-to-date period reached ¥256,423,754.46, an increase of 97.85%[3]. - The cash flow from operating activities for the first three quarters of 2022 was CNY 256,423,754.46, significantly higher than CNY 129,608,275.50 in the same period of 2021, marking a growth of 97.9%[22]. - The cash flow from investing activities showed a net inflow of CNY 38,903,485.43 in Q3 2022, a recovery from a net outflow of CNY -207,863,706.39 in Q3 2021[23]. - The net cash flow from operating activities for the first three quarters of 2022 was approximately ¥256.49 million, a 98% increase compared to ¥129.61 million in the same period of 2021[32]. - The net cash flow from investment activities for Q3 2022 was approximately ¥20.72 million, a significant improvement from a negative cash flow of ¥207.86 million in Q3 2021[33]. Assets and Liabilities - The total assets at the end of Q3 2022 were ¥2,707,557,913.27, an increase of 8.07% from the end of the previous year[4]. - Total assets as of September 30, 2022, were RMB 2,707,557,913.27, up from RMB 2,505,486,058.34 at the end of 2021, representing an increase of approximately 8.1%[15]. - Total liabilities as of September 30, 2022, were RMB 367,937,438.98, compared to RMB 305,048,176.89 at the end of 2021, indicating an increase of about 20.7%[14]. - The total liabilities as of September 30, 2022, were ¥367,908,796.97, compared to ¥305,043,169.84 at the end of 2021, indicating an increase of 20.6%[27]. Shareholder Information - The company had a total of 15,243 common shareholders at the end of the reporting period[8]. - The top shareholder, Chulin, held 45.99% of the shares, totaling 103,725,189 shares[9]. Research and Development - Research and development expenses for the first three quarters of 2022 amounted to RMB 26,084,397.73, up from RMB 19,532,144.91 in the same period of 2021, reflecting a growth of approximately 33.4%[18]. - Research and development expenses for the first three quarters of 2022 were ¥26,084,397.73, up 33.4% from ¥19,532,144.91 in 2021, highlighting a commitment to innovation[29]. Future Strategies - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the provided content[18]. - The company has plans for future growth strategies, including potential mergers and acquisitions, although specific details were not provided in the content[18].